Sara M. Hanning

927 total citations · 1 hit paper
37 papers, 672 citations indexed

About

Sara M. Hanning is a scholar working on Pediatrics, Perinatology and Child Health, Physiology and Pharmacology. According to data from OpenAlex, Sara M. Hanning has authored 37 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 7 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Sara M. Hanning's work include Pharmaceutical studies and practices (7 papers), Salivary Gland Disorders and Functions (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Sara M. Hanning is often cited by papers focused on Pharmaceutical studies and practices (7 papers), Salivary Gland Disorders and Functions (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Sara M. Hanning collaborates with scholars based in New Zealand, United Kingdom and Australia. Sara M. Hanning's co-authors include Jingyuan Wen, Michelle Locke, Shuo Chen, James R. Falconer, Zimei Wu, Catherine Tuleu, Natalie J. Medlicott, Mine Orlu Gul, Darren Svirskis and Saeid Baroutian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cleaner Production and Journal of Controlled Release.

In The Last Decade

Sara M. Hanning

33 papers receiving 653 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications

2019 328 citations Sara M. Hanning et al. profile →

Peers

Countries citing papers authored by Sara M. Hanning

Since Specialization

Citations

This map shows the geographic impact of Sara M. Hanning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara M. Hanning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara M. Hanning more than expected).

Fields of papers citing papers by Sara M. Hanning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara M. Hanning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara M. Hanning. The network helps show where Sara M. Hanning may publish in the future.

Co-authorship network of co-authors of Sara M. Hanning

This figure shows the co-authorship network connecting the top 25 collaborators of Sara M. Hanning. A scholar is included among the top collaborators of Sara M. Hanning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara M. Hanning. Sara M. Hanning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A survey of prefilled, bolus-dose syringes containing single medications compounded in community pharmacies for palliative care patients in Tāmaki Makaurau Auckland, Aotearoa New Zealand 2025 ·Journal of Primary Health Care ·Ewen A. Griffiths, Sara M. Hanning, (unknown), (unknown)	0
2	Preparing pharmacists for disaster management and practice: A participatory scoping review 2025 ·Currents in Pharmacy Teaching and Learning ·(unknown), (unknown), Naoko Arakawa, Anthony Cox, Carl R. Schneider, Sara M. Hanning	0
3	Preparing pharmacists for disaster management and practice: protocol for a scoping review with a participatory approach 2025 ·BMJ Open ·(unknown), Shane Scahill, Naoko Arakawa, Anthony Cox, Carl R. Schneider, Sara M. Hanning	1
4	Diazoxide for Severe or Recurrent Neonatal Hypoglycemia 2024 ·JAMA Network Open ·(unknown), (unknown), Jane M. Alsweiler, Sara M. Hanning, Michael P. Meyer, (unknown), Wayne S. Cutfield, Jenny Rogers, Gregory D. Gamble, J. Geoffrey Chase, Jane E. Harding, Christopher J. D. McKinlay	1
5	Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis 2024 ·Journal of Perinatology ·(unknown), Sara M. Hanning, Christopher J. D. McKinlay, Jane M. Alsweiler	9
6	Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023 2023 ·Current Pain and Headache Reports ·(unknown), Saeid Baroutian, Sara M. Hanning	3
7	Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide 2023 ·Heliyon ·(unknown), (unknown), Christopher J. D. McKinlay, Jane M. Alsweiler, Sara M. Hanning	1
8	Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial 2022 ·BMJ Open ·(unknown), (unknown), Jane M. Alsweiler, Sara M. Hanning, Michael P. Meyer, (unknown), Wayne S. Cutfield, Jenny Rogers, Greg Gamble, J. Geoffrey Chase, Jane E. Harding, Christopher J. D. McKinlay	2
9	Hydrothermal deconstruction of two antibiotics (amoxicillin and metronidazole) 2021 ·Journal of Cleaner Production ·(unknown), Teck Nam Ang, Sara M. Hanning, Darren Svirskis, (unknown), Morgan Taylor, L.J. Wright, Saeid Baroutian	23
10	Rectal bioavailability of amoxicillin sodium in rabbits: Effects of suppository base and drug dose 2021 ·Journal of Controlled Release ·(unknown), Sara M. Hanning, Satya Amirapu, Zimei Wu	4
11	Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children 2020 ·Drug Delivery and Translational Research ·Sara M. Hanning, (unknown), (unknown), Mine Orlu, Cornelius C. Dodoo, Simon Gaisford, Catherine Tuleu	10
12	Comparing human peritoneal fluid and phosphate-buffered saline for drug delivery: do we need bio-relevant media? 2018 ·Drug Delivery and Translational Research ·(unknown), (unknown), Bruce Su’a, (unknown), Mahima Bansal, Sara M. Hanning, Manisha Sharma, (unknown), Jeff Harrison, (unknown), Gavin P. Andrews, David S. Jones, Andrew Hill, Darren Svirskis	13
13	The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial 2017 ·BMJ Open ·Antje Neubert, Manuel A. Baarslag, Monique van Dijk, Joost van Rosmalen, Joseph F. Standing, Yucheng Sheng, Wolfgang Rascher, (unknown), (unknown), (unknown), Sara M. Hanning, Tuuli Metsvaht, Viviana Giannuzzi, Peter Larsson, Pavla Pokorná, Alessandra Simonetti, Dick Tibboel	13
14	A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation‐induced xerostomia 2017 ·Journal of Oral Rehabilitation ·(unknown), Natalie J. Medlicott, Alison M. Rich, Sara M. Hanning, (unknown)	13
15	Quality and clinical supply considerations of Paediatric Investigation Plans for IV preparations—A case study with the FP7 CloSed project 2016 ·International Journal of Pharmaceutics ·Sara M. Hanning, Mine Orlu Gul, (unknown), Manuel A. Baarslag, Antje Neubert, Catherine Tuleu	1
16	Patient centric formulations for paediatrics and geriatrics: Similarities and differences 2016 ·International Journal of Pharmaceutics ·Sara M. Hanning, Felipe L. Lopez, Ian Chi Kei Wong, Terry B. Ernest, Catherine Tuleu, Mine Orlu Gul	44
17	Oil-based compositions as saliva substitutes: A pilot study to investigate in-mouth retention 2016 ·International Journal of Pharmaceutics ·Sara M. Hanning, Natalie J. Medlicott	5
18	Investigation into the dosage form attributes of currently UK licensed cardiovascular and Parkinson's disease drug products 2014 ·International Journal of Pharmaceutics ·Sara M. Hanning, (unknown), Mine Orlu-Gul	3
19	The use of lithium as a marker for the retention of liquids in the oral cavity after rinsing 2013 ·Clinical Oral Investigations ·Sara M. Hanning, Jules Kieser, M.M. Ferguson, Malcolm Reid, Natalie J. Medlicott	2
20	Lecithin-based emulsions for potential use as saliva substitutes in patients with xerostomia – viscoelastic properties 2013 ·International Journal of Pharmaceutics ·Sara M. Hanning, Tao Yu, David S. Jones, Gavin P. Andrews, Jules Kieser, Natalie J. Medlicott	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact